Home Community Using An Artificial Intelligence Algorithm, Researchers at MIT and McMaster University have identified a brand new Antibiotic that may Kill a Variety of Bacteria that’s Chargeable for Many Drug-Resistant Infections

Using An Artificial Intelligence Algorithm, Researchers at MIT and McMaster University have identified a brand new Antibiotic that may Kill a Variety of Bacteria that’s Chargeable for Many Drug-Resistant Infections

0
Using An Artificial Intelligence Algorithm, Researchers at MIT and McMaster University have identified a brand new Antibiotic that may Kill a Variety of Bacteria that’s Chargeable for Many Drug-Resistant Infections

MIT and McMaster University researchers have utilized artificial intelligence (AI) to find a brand new antibiotic that effectively kills drug-resistant bacteria, particularly Acinetobacter baumannii, a species commonly present in hospitals. This bacterium is related to severe infections corresponding to pneumonia and meningitis, and it’s a number one reason behind infections amongst wounded soldiers. The rise of antibiotic-resistant bacteria necessitates the event of recent antibiotics, and the usage of AI in drug discovery holds great promise.

The researchers employed a machine-learning algorithm to judge nearly 7,000 chemical compounds and discover a possible drug that inhibits the expansion of Acinetobacterbaumannii. The AI algorithm was trained to acknowledge patterns in extensive data sets and predict the inhibitory properties of chemical compounds. This approach enables the identification of novel antibiotics with distinct chemical structures in comparison with existing drugs.

Of their initial study, the team successfully trained the AI algorithm to discover compounds that might inhibit the expansion of E. coli, yielding a molecule named halicin. Halicin demonstrated the flexibility to kill multiple bacterial species resistant to traditional treatment. Constructing on this success, the researchers focused on combatting A. baumannii, a major threat as a result of its multidrug resistance.

🚀 JOIN the fastest ML Subreddit Community

To coach their computational model, the researchers exposed A. baumannii to numerous chemical compounds and observed their inhibitory effects. The AI algorithm analyzed the chemical structures of those compounds and learned to associate specific features with growth inhibition. Next, the algorithm analyzed over 6,000 compounds from the Drug Repurposing Hub on the Broad Institute, quickly identifying a number of hundred top candidates. From there, the team chosen 240 compounds for experimental testing within the laboratory, prioritizing those with structurally distinct properties from existing antibiotics.

The tests yielded nine potential antibiotics, including one particularly potent compound. Originally investigated as a diabetes drug, this compound effectively kills A. baumannii while leaving other bacterial species unaffected. This narrow spectrum of activity minimizes the chance of bacterial resistance and reduces harm to helpful gut bacteria that aid in stopping opportunistic infections.

The researchers named the potent antibiotic abaucin and demonstrated its efficacy in treating A. baumannii wound infections in mice. Lab tests confirmed its effectiveness against various drug-resistant strains of A. baumannii isolated from human patients. Further investigations revealed that abaucin interferes with lipoprotein trafficking, a cellular process involved in protein transportation. Notably, abaucin selectively targets A. baumannii despite this process being present in all Gram-negative bacteria. The researchers suggest that subtle differences in how A. baumannii performs lipoprotein trafficking contribute to the drug’s selectivity.

The team is collaborating with McMaster researchers to optimize abaucin’s medicinal properties for potential use in patients. Moreover, they plan to use their AI modeling approach to discover potential antibiotics for other drug-resistant infections brought on by bacteria corresponding to Staphylococcus aureus and Pseudomonas aeruginosa.

The successful application of AI in identifying a novel antibiotic highlights its potential to speed up and expand the seek for effective treatments against drug-resistant bacteria. This research addresses the urgent need for brand spanking new antibiotics and demonstrates the facility of AI in revolutionizing the sector of drug discovery.


Check Out The Paper and Reference MIT Article. Don’t forget to affix our 23k+ ML SubReddit, Discord Channel, and Email Newsletter, where we share the most recent AI research news, cool AI projects, and more. If you may have any questions regarding the above article or if we missed anything, be happy to email us at Asif@marktechpost.com

🚀 Check Out 100’s AI Tools in AI Tools Club


Niharika

” data-medium-file=”https://www.marktechpost.com/wp-content/uploads/2023/01/1674480782181-Niharika-Singh-264×300.jpg” data-large-file=”https://www.marktechpost.com/wp-content/uploads/2023/01/1674480782181-Niharika-Singh-902×1024.jpg”>

Niharika is a Technical consulting intern at Marktechpost. She is a 3rd 12 months undergraduate, currently pursuing her B.Tech from Indian Institute of Technology(IIT), Kharagpur. She is a highly enthusiastic individual with a keen interest in Machine learning, Data science and AI and an avid reader of the most recent developments in these fields.


Try https://aitoolsclub.com to seek out 100’s of Cool AI Tools

LEAVE A REPLY

Please enter your comment!
Please enter your name here